BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27059462)

  • 1. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.
    Xie QY; Almudevar A; Whitney-Miller CL; Barry CT; McCall MN
    BMC Med Genomics; 2016 Apr; 9():18. PubMed ID: 27059462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
    Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
    Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation.
    Barry CT; D'Souza M; McCall M; Safadjou S; Ryan C; Kashyap R; Marroquin C; Orloff M; Almudevar A; Godfrey TE
    Am J Transplant; 2012 Feb; 12(2):428-37. PubMed ID: 22008552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic role of microRNA-423-5p in hepatocellular carcinoma.
    Wu LM; Ji JS; Yang Z; Xing CY; Pan TT; Xie HY; Zhang F; Zhuang L; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):613-8. PubMed ID: 26663009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
    Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
    Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
    Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
    Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
    Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
    Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
    Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
    Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
    Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.
    Bai F; Zhou H; Ma M; Guan C; Lyu J; Meng QH
    Mol Oncol; 2018 Jun; 12(7):1125-1137. PubMed ID: 29719937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
    von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
    BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma.
    Wei L; Lian B; Zhang Y; Li W; Gu J; He X; Xie L
    BMC Genomics; 2014; 15 Suppl 1(Suppl 1):S13. PubMed ID: 24564407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.